Results 141 to 150 of about 41,743 (197)

Novel treatment approaches for keloids and hypertrophic scars in skin of colour

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 3, Page 535-536, March 2026.
Andy D. Lee, Sean Jeong, Rachel Kim, Kristen A. R. Yee, Megan Park, Ryan S. Q. Geng, Cathryn Sibbald, Robert Bobotsis   +7 more
wiley   +1 more source

Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review. [PDF]

Health Sci Rep
Jafarzadeh A, Darvishi MA, Khosravi M, Roohaninasab M, Goodarzi A.   +4 more
europepmc   +1 more source

Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. [PDF]

Cureus
Ahmad F, Hussain T, Gunaratne CH, Collum J, Ghaffar A, Gharbia K.   +5 more
europepmc   +1 more source

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3-Year J-Post-Marketing Surveillance. [PDF]

Int J Rheum Dis
Yamaoka K, Hoshi M, Endo Y, Hirano T.
europepmc   +1 more source

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis. [PDF]

Cureus
Burashed KK, AlAbbasi FA.
europepmc   +1 more source

Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database. [PDF]

Front Public Health
Kong L, Liu X, Feng Y.
europepmc   +1 more source

Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia. [PDF]

Cureus
Aleidi FA, Almadhi MO, Altassan ZH, Alotaibi LF, Almutairi B, Khalaf M, Almansour HM, Alhowil RR, Alotaibi A, Alsultani SA, Fahad R, Thawab F.   +11 more
europepmc   +1 more source

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials. [PDF]

BMJ Open
Strand V, Schulze-Koops H, Al-Emadi S, Kinch CD, Gruben D, Germino R, Connell CA, Mysler E.   +7 more
europepmc   +1 more source

Revisiting Janus kinases as molecular drug targets for rheumatic diseases. [PDF]

Front Med (Lausanne)
Kwon S.
europepmc   +1 more source

Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report. [PDF]

Clin Case Rep
Bogojevic M, Medjedovic R, Markovic M, Bakic N, Pravilovic Lutovac D.   +4 more
europepmc   +1 more source